Bipolar disorder (BD) is a lifelong severe psychiatric condition with high morbidity, disability and excess mortality. The longitudinal clinical trajectory of BD is significantly modified by ...

Dr. Mirko Manchia at a recent national conference on neuropsychopharmacology in Rome discussing precision medicine approaches in psychiatry. CAGLIARI, Sardinia, Italy, 8 July 2025 – In a comprehensive ...

Pharmacogenomics (PGx) involves the study of patients’ unique genes to predict their individual response to drugs. 1,3 In assessments of the 12 most important pharmacogenes, at least 1 clinically ...

Awards will expand projects into new diseases like RA and bipolar disorder and fortify resources. NIH plans on spending $161.3 million over the next five years to expand the Pharmacogenomics Research ...

An international team, led by University of California, San Diego School of Medicine researchers, has been awarded a $6.5 million grant from the National Institutes of Health (NIH) to study the ...

For many years now, genetic–epidemiologic studies using family, twin and adoption designs have been consistently indicating that genetic factors play a role in the etiology of BD. 4 This support ...

Pharmacogenomics is a tool that can assist providers in optimizing drug selection and dosing, help avoid costly adverse effects, and identify responders and non-responders to medications. New and ...

Please provide your email address to receive an email when new articles are posted on . Pharmacists can play a key role in integrating pharmacogenomics data into clinical practice. Antiplatelet, ...

The authors gratefully acknowledge M Groeneweg for commenting on the manuscript and P Niola for her assistance with table preparation. TPH1 121 MDD and BD patients treated with paroxetine Association ...